Menstrual cycle and gynecologic pathology in menstrual-related migraine
https://doi.org/10.14412/2074-2711-2021-4-12-17
Abstract
Migraine is the first most frequent cause of disability among women of reproductive age globally, and up to 60% of patients note the association of headache attacks with menstruation.
Objective: to determine the features of menstrual cycle and gynecologic pathology in women with menstrual-related migraine (MRM).
Patients and methods. A prospective comparative study included 69 women of reproductive age with a migraine diagnosis who did not receive hormonal contraception. Depending on the association of migraine attacks with menstruation (according to headache diaries), the patients were divided into two groups: the 1st group consisted of 44 patients with MRM; group 2 — 25 patients with non-menstrual migraine (without the association of attacks with menstruation).
Results and discussion. Patients with MRM had heavier menstrual bleeding, longer menstruations (more than six days), abnormal menstrual cycle length and regularity, dysmenorrhea. In addition, the obtained data indicate a comorbid estrogen-associated gynecological pathology (endometriosis, adenomyosis, endometrial polyps, myoma) in MRM.
Conclusion. Presumably, the hypothalamic-pituitary-ovarian axis dysfunction plays the leading role in the MRM. It presents with menstrual cycle abnormalities and increased presence of estrogen-associated gynecological pathology, which should be considered during patient evaluation and suggesting recommendations.
About the Authors
E. A. Kiryanova
Department of Nervous System Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Ekaterina Andreevna Kiryanova.
11, Rossolimo St., Build. 1, Moscow 119021.
Competing Interests:
There are no conflicts of interest.
G. R. Tabeeva
Department of Nervous System Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
11, Rossolimo St., Build. 1, Moscow 119021.
Competing Interests:
There are no conflicts of interest.
References
1. Buse DC, Fanning KM, Reed ML. Life with Migraine, Effect on Relationships, Career and Finances, and Overall Health and WellBeing: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2019;59(8):1286-99. doi: 10.1111/head.13613
2. Scher AI, Wang SJ, Katsarava Z. Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Cephalalgia. 2019;39(2):296-305. doi: 10.1177/0333102418786266
3. Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16(1):76-87. doi: 10.1016/S1474-4422(16)30293-9
4. Headache Classification Committee of the International Headache Society. HIS The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi: 10.1177/0333102417738202
5. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972;22(4):355-5. doi: 10.1212/WNL.22.4.355
6. Petrovski BE, Vetvik KG, Lundqvist C, Eberhard-Gran M. Characteristics of menstrual versus non-menstrual migraine during pregnancy: a longitudinal population-based study. J Headache Pain. 2018;19(1):27. doi: 10.1186/s10194-018-0853-3
7. Ansari T, Lagman-Bartolome AM, Monsour D, Lay C. Management of Menstrual Migraine. Curr Neurol Neurosci Rep. 2020;20(10):1-6. doi: 10.1007/s11910-020-01067-x
8. Fernandez-Martinez E, Dolores M, Abreu-Sanchez A, et al. Menstrual migraine among Spanish university students. J Pediatr Nurs. 2020;56:e1-e6. doi: 10.1016/j.pedn.2020.06.013
9. Spierings EL, Padamsee A. Menstrual-cycle and menstruation disorders in episodic vs chronic migraine: an exploratory study. Pain Med. 2015;16(7):1426-32. doi: 10.1111/pme.12788
10. Mannix LK. Menstrual-related pain conditions: dysmenorrhea and migraine. J Womens Health (Larchmt). 2008 Jun;17(5):879-91. doi: 10.1089/jwh.2007.0440
11. Abreu-Sanchez A, Parra-Fernandez ML, Onieva-Zafra MD, et al. Type of dysmenorrhea, menstrual characteristics and symptoms in nursing students in Southern Spain. Healthcare (Basel). 2020 Aug 26;8(3):302. doi: 10.3390/healthcare8030302
12. Tabeyeva GR, Gromova SA, Koreshkina MI. Gynecological pathology in patients with menstrual and non-menstrual migraines. Problemy zhenskogo zdorov'ya. 2013;8(3):44-51 (In Russ.).
13. Nnoaham KE, Hummelshoj L, Kennedy SH, et al; World Endometriosis Research Foundation Women's Health Symptom Survey Consortium. Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study. Fertil Steril. 2012 Sep;98(3):692-701.e5. doi: 10.1016/j.fertnstert.2012.04.022. Epub 2012 May 30.
14. Munro MG, Critchley HO, Broder MS, Fraser IS; FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet. 2011 Apr;113(1):3-13. doi: 10.1016/j.ijgo.2010.11.011. Epub 2011 Feb 22.
15. Witteveen H, van den Berg P, Vermeulen G. Treatment of menstrual migraine; multidisciplinary or mono-disciplinary approach. J Headache Pain. 2017 Dec;18(1):45. doi: 10.1186/s10194-017-0752-z. Epub 2017 Apr 17.
16. Vetvik KG, MacGregor EA. Menstrual migraine: a distinct disorder needing greater recognition. Lancet Neurol. 2021 Apr;20(4):304-15. doi: 10.1016/S1474-4422(20)30482-8. Epub 2021 Feb 15.
17. MacGregor EA. Contraception and headache. Headache. 2013 Feb;53(2):247-76. doi: 10.1111/head.12035
18. Sacco S, Merki-Feld GS, Egidius KL, et al. Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH). J Headache Pain. 2018 Aug 31;19(1):76. doi: 10.1186/s10194-018-0896-5
19. Huang JH, Duan H, Wang S, Wang YY. Estrogen 17e-estradiol accelerates the proliferation of uterine junctional zone smooth muscle cells via the let7a/Lin28B axis in adenomyosis. Mol Med Rep. 2021;23(5):1-8. doi: 10.3892/mmr.2021.11976
20. Bulun SE, Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005 Sep;57(3):359-83. doi: 10.1124/pr.57.3.6
21. Kurioka H, Takahashi K, Ueda T, et al. Endometriosis and uterine leiomyomata with ovarian granulosa cell tumour. Hum Reprod. 1998 May;13(5):1357-60. doi: 10.1093/hum-rep/13.5.1357
22. Uimari O, Jarvela I, Ryynanen M. Do symptomatic endometriosis and uterine fibroids appear together? J Hum Reprod Sci. 2011;4(1):34-8. doi: 10.4103/0974-1208.82358
23. Li L, Liu R, Dong Z, et al. Impact of ESR1 gene polymorphisms on migraine susceptibility: a meta-analysis. Medicine. 2015 Sep;94(35):e0976. doi: 10.1097/MD.0000000000000976
24. Chen Q, Zhang W, Sadana N, Chen X. Estrogen receptors in pain modulation: cellular signaling. Biol Sex Differ. 2021 Feb 10;12(1):22. doi: 10.1186/s13293-021-00364-5
25. Karsan N, Goadsby PJ. Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol. 2018 Dec;14(12):699-710. doi: 10.1038/s41582-018-0098-4
26. Schulte LH, May A.The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(Pt 7):1987-93. doi: 10.1093/brain/aww097
Review
For citations:
Kiryanova E.A., Tabeeva G.R. Menstrual cycle and gynecologic pathology in menstrual-related migraine. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(4):12-17. (In Russ.) https://doi.org/10.14412/2074-2711-2021-4-12-17
Views: 254
Email this article 